Codexis to Participate in Cantor Global Healthcare Conference
Codexis (NASDAQ:CDXS), a provider of enzymatic solutions for therapeutic manufacturing, announced its participation in the upcoming Cantor Global Healthcare Conference. The event will take place from September 3-5, 2025, in New York.
The company's management will engage in a fireside chat on September 4, 2025, at 3:55 pm ET. Investors can access a live webcast through Codexis's investor relations website, with a replay available for 90 days after the event.
Codexis (NASDAQ:CDXS), fornitore di soluzioni enzimatiche per la produzione di terapie, ha confermato la propria partecipazione al Cantor Global Healthcare Conference. L'evento si terrà dal 3 al 5 settembre 2025 a New York.
La direzione dell'azienda parteciperà a un fireside chat il 4 settembre 2025 alle 15:55 ET. Gli investitori potranno seguire la diretta via webcast sul sito investor relations di Codexis; la registrazione resterà disponibile per 90 giorni dopo l'evento.
Codexis (NASDAQ:CDXS), proveedor de soluciones enzimáticas para la fabricación de terapias, ha anunciado su participación en el Cantor Global Healthcare Conference. El evento se celebrará del 3 al 5 de septiembre de 2025 en Nueva York.
La dirección de la compañía intervendrá en un fireside chat el 4 de septiembre de 2025 a las 3:55 pm ET. Los inversores podrán acceder a la retransmisión en directo a través de la web de relaciones con inversores de Codexis; la grabación estará disponible durante 90 días tras el evento.
Codexis (NASDAQ:CDXS), 치료제 제조를 위한 효소 솔루션 제공업체가 Cantor Global Healthcare Conference에 참여한다고 발표했습니다. 행사는 2025년 9월 3일부터 5일까지 뉴욕에서 개최됩니다.
회사의 경영진은 2025년 9월 4일 오후 3시 55분(동부시간)에 파이어사이드 채팅에 참여합니다. 투자자는 Codexis 투자자 관계 웹사이트를 통해 라이브 웹캐스트를 시청할 수 있으며, 행사가 끝난 후 90일 동안 다시보기가 제공됩니다.
Codexis (NASDAQ:CDXS), fournisseur de solutions enzymatiques pour la fabrication de thérapies, a annoncé sa participation à la Cantor Global Healthcare Conference. L'événement se tiendra du 3 au 5 septembre 2025 à New York.
La direction de la société participera à un fireside chat le 4 septembre 2025 à 15h55 ET. Les investisseurs pourront suivre la retransmission en direct via le site relations investisseurs de Codexis ; le replay sera disponible pendant 90 jours après l'événement.
Codexis (NASDAQ:CDXS), Anbieter enzymatischer Lösungen für die therapeutische Herstellung, hat seine Teilnahme an der Cantor Global Healthcare Conference angekündigt. Die Veranstaltung findet vom 3. bis 5. September 2025 in New York statt.
Das Management des Unternehmens wird am 4. September 2025 um 15:55 Uhr ET an einem Fireside-Chat teilnehmen. Investoren können die Live-Übertragung über die Investor-Relations-Website von Codexis verfolgen; eine Aufzeichnung steht 90 Tage nach der Veranstaltung zur Verfügung.
- None.
- None.
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 3-5, 2025, in New York, New York.
Management will participate in a fireside chat on Thursday, September 4, 2025, at 3:55 pm ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay will be archived for 90 days following the event.
About Codexis
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis® manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Georgia Erbez
650-421-8100
FAQ
When is Codexis (CDXS) presenting at the Cantor Global Healthcare Conference 2025?
How can investors watch Codexis's presentation at the Cantor Healthcare Conference?
Where is the 2025 Cantor Global Healthcare Conference being held?
What type of company is Codexis (CDXS)?
